Niranib 100mg capsule

Niranib 100mg capsule is an anti-cancer drug which contains Niraparib, a PARP enzyme inhibitor that is used for maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

It inhibits PARP enzymatic enzymes NIRANIB 100 MG CAPSULE IN PAKISTAN  usually repair any damage to DNA in cells.Inhibiting them stops the cancer cells from repairing themselves. This results in growth arrest and death of cancer cells.

It comes in a dose of 300 mg (three 100 mg capsules).This is taken once daily, preferably at the same time each day. The capsules should be swallowed whole with water. They should not be chewed or NIRANIB 100 MG CAPSULE PRICE IN PAKISTAN broken up.It can be taken with or without meals. Taking it at night could reduce nausea.Dosage may be adjusted according to your weight or blood tests results.

Nausea and vomiting.Tiredness and weakness.Low levels of certain types of blood cells like anemia and throm bocyto penia. Constipation. Decreased appetite.

Niraparib (Zejula) is an oral targeted prescription cancer drug used as a maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers, who have had a response to platinum-based chemotherapy.

No, niraparib (Zejula) is not traditional chemotherapy. It is one of the targeted cancer treatments and is considered as a PARP inhibitor.